OPKO Health to Hold Virtual R&D Day on March 20, 2023

Mar 9, 2023

OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate

Mar 8, 2023

OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results

Feb 23, 2023

OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023

Feb 16, 2023

OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference

Jan 3, 2023

OPKO Health Reports Third Quarter 2022 Business Highlights and Financial Results

Nov 8, 2022

OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022

Nov 1, 2022

OPKO Health Announces Leadership Changes for BioReference Laboratories

Aug 16, 2022

OPKO Health Reports 2022 Second Quarter Business Highlights and Financial Results

Aug 4, 2022

OPKO Health to Report Second Quarter 2022 Financial Results on August 4, 2022

Jul 25, 2022